X0407 4/A 2023-02-17 2023-02-23 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001366244 Palleiko Benjamin L C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142 0 1 0 0 President, CFO, CBO & Sec'y 0 Restricted Stock Unit 2023-02-17 4 M 0 6944 0.00 D Common Stock 6944 76390 D The original Form 4 filed on February 23, 2023, is being amended by this Form 4 amendment solely to correct an administrative error, which mis-reported the vesting schedule and the restricted stock unit as a performance restricted stock unit. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 17, 2022, subject to continued service through each vesting date. /s/ Benjamin L. Palleiko 2023-05-22